Cutmix-150 · Test P + Tren A + Masteron P · 10ml
Cutmix-150 Injectable Cutting Blend
Cutmix-150 combines three short-ester injectable steroids in one fixed-ratio blend: Testosterone Propionate, Trenbolone Acetate and Drostanolone Propionate (Masteron). Each ml contains 50mg of each compound, for 150mg total steroid per ml and 1,500mg total blend in a 10ml bottle.
150mg/ml
50mg + 50mg + 50mg
10ml
1,500mg
Exact composition
What Is in 1ml of Cutmix-150?
| Compound | Amount Per 1ml | Practical Role in the Blend |
|---|---|---|
| Testosterone Propionate | 50mg | Short-ester testosterone base |
| Trenbolone Acetate | 50mg | Potent short-ester anabolic-androgenic component |
| Drostanolone Propionate | 50mg | Short-ester Masteron commonly associated with cutting use |
| Total | 150mg/ml | Fixed 1:1:1 ratio |
The fixed ratio is the main convenience of Cutmix: one injection delivers all three compounds together. It also means every dose change increases or decreases Testosterone Propionate, Trenbolone Acetate and Drostanolone Propionate at the same time.
Quick reference
Cutmix-150 Dosage
150mg
Every other day · 1ml
150–225mg
Every other day · 1–1.5ml
225–300mg
Every other day · 1.5–2ml
6–10 weeks
Current Thai Anabolics reference
The amounts above refer to the TOTAL Cutmix blend per injection — not 150mg of each steroid. At 1ml, the injection contains 50mg Testosterone Propionate + 50mg Trenbolone Acetate + 50mg Drostanolone Propionate.
Dose math for the actual blend
How Much of Each Compound Are You Injecting?
| Cutmix Per Injection | Injection Volume | Test P | Tren A | Masteron P |
|---|---|---|---|---|
| 150mg | 1.0ml | 50mg | 50mg | 50mg |
| 225mg | 1.5ml | 75mg | 75mg | 75mg |
| 300mg | 2.0ml | 100mg | 100mg | 100mg |
Every-other-day schedule: because an EOD schedule averages about 3.5 injections per week, 1ml EOD averages approximately 525mg total blend per week — about 175mg/week of each component. At 1.5ml EOD, that rises to about 787.5mg total blend per week, or 262.5mg/week of each component.
Three-day-per-week schedule: 1ml on Monday, Wednesday and Friday equals 450mg total blend per week, consisting of 150mg/week of each component. These schedules are therefore not mathematically identical even when the amount per injection is the same.
Why the blend is used
Cutmix for Cutting Cycles
Cutmix packages three compounds commonly encountered in physique-focused use into one short-ester blend. Peer-reviewed reviews of real-world AAS use identify Testosterone Propionate and Drostanolone Propionate among injectable compounds used in cutting phases, while Trenbolone is a potent androgen-receptor agonist with strong anabolic activity.[1][2]
The practical appeal is convenience and a fixed 1:1:1 ratio rather than needing three separate injections of the individual compounds.
Short-ester format
Why Cutmix Is Injected Frequently
Cutmix uses Testosterone Propionate, Trenbolone Acetate and Drostanolone Propionate rather than long-acting esters. The current Thai Anabolics schedule is therefore every other day or a practical three-day-per-week pattern such as Monday, Wednesday and Friday.
Human pharmacokinetic data are much stronger for Testosterone Propionate than for the other two bodybuilding esters, so this page does not invent one precise “Cutmix half-life.”
Important correction
Does Cutmix Cause Water Retention?
The old description said Cutmix provides its cutting effects “all without water retention.” That is too absolute because one-third of the blend is Testosterone Propionate, and testosterone can be converted to estradiol through aromatase.
Trenbolone does not aromatize to estrogen, and Drostanolone is DHT-derived and is not an aromatizing steroid. However, estrogen production from the Testosterone Propionate component still means some users can experience estrogen-related water retention depending on dose and individual response.[2][3]
A better description is that Cutmix is designed as a short-ester cutting blend and contains two non-aromatizing components, rather than claiming that water retention is impossible.
Cycle planning
Stacking With Cutmix
Remember that Cutmix is already a three-compound stack. At 1ml per injection, you are already using Testosterone Propionate, Trenbolone Acetate and Masteron Propionate together.
The current Thai Anabolics examples add compounds such as Anavar, Winstrol or Clenbuterol for cutting-focused use. Because the base product already contains three active steroids, total compound exposure should be calculated from the entire cycle rather than treating “1ml Cutmix” as though it were one 150mg steroid.
This fixed-ratio design is convenient, but it also means the Trenbolone amount cannot be changed independently from the Testosterone and Masteron amounts within the same Cutmix dose.
10ml bottle
How Long Will One Cutmix Bottle Last?
1ml EOD: approximately 20 days
1ml three times weekly: approximately 3.3 weeks
1.5ml EOD: approximately 13 days
2ml EOD: approximately 10 days
After the cycle
PCT After Cutmix
The current Thai Anabolics reference is to begin PCT around 3–5 days after the final Cutmix injection using a SERM such as Nolvadex and/or Clomid.
That is a practical reference for this short-ester blend, not a universally validated clinical rule. Post-AAS endocrine recovery varies and standardized PCT protocols remain incompletely studied.[4] See PCT products in Thailand →
Independent product testing
Cutmix-150 Lab Report
The current report attached to the live Cutmix page identifies the sample as Cutmix 150 and reports an HPLC result of 154.01mg/ml against a stated specification of NLT 150mg/ml.
OnSet Biological Testing Laboratory
25-518406
7 March 2025
NKS1100
HPLC
154.01mg/ml
Specification: NLT 150mg/ml
Thailand delivery
Buy Cutmix-150 in Thailand
Thai Anabolics lists Cutmix-150 as a 10ml injectable blend containing 50mg/ml Testosterone Propionate, 50mg/ml Trenbolone Acetate and 50mg/ml Drostanolone Propionate. Current price, stock status and waitlist availability are always shown in the purchase section at the top of this page.
Sources
Cutmix Compound Sources
- Mullen C, Whalley BJ, Schifano F, Baker JS. Anabolic androgenic steroid abuse in the United Kingdom: An update. British Journal of Pharmacology. 2020;177(10):2180–2198. Review of non-medical AAS use patterns including Testosterone Propionate and Drostanolone Propionate in cutting contexts. View full text
- Yarrow JF, McCoy SC, Borst SE. Tissue selectivity and potential clinical applications of trenbolone: a potent anabolic steroid with reduced androgenic and estrogenic activity. Steroids. 2010;75(6):377–389. Reviews Trenbolone androgen-receptor activity and non-aromatizing metabolism. View on PubMed
- Swerdloff RS, Wang C. Dihydrotestosterone: a rationale for its use as a non-aromatizable androgen replacement therapeutic agent. Baillière’s Clinical Endocrinology and Metabolism. 1998;12(3):501–506. Reviews DHT as a potent androgen that cannot be aromatized to estrogen; Drostanolone is DHT-derived. View on PubMed
- Kanayama G, Hudson JI, Pope HG Jr, et al. Physical, psychological and biochemical recovery from anabolic steroid-induced hypogonadism: a scoping review. Endocrine Connections. 2023. Reviews recovery after AAS cessation and the limitations of standardized post-cycle evidence. View full text









75 reviews for Cutmix-150